Search Results - "Wright, Emily K"

Maternal thiopurine metabolism during pregnancy in inflammatory bowel disease and clearance of thiopurine metabolites and outcomes in exposed neonates by Flanagan, Emma, Wright, Emily K., Hardikar, Winita, Sparrow, Miles P., Connell, William R., Kamm, Michael A., De Cruz, Peter, Brown, Steven J., Thompson, Alexander, Greenway, Anthea, Westley, Ian, Barclay, Murray, Ross, Alyson L., Kiburg, Katerina V., Bell, Sally J.

“…Summary Background Azathioprine and mercaptopurine are considered safe during pregnancy. However, the pharmacokinetic effects of pregnancy on thiopurine…”
Get full text

Evaluation and management of ileal pouch-anal anastamosis (IPAA) complications in pregnancy, and the impacts of an IPAA on fertility by Prentice, Ralley E., Wright, Emily K., Flanagan, Emma, Kamm, Michael A, Goldberg, Rimma, Ross, Alyson L., Burns, Megan, Bell, Sally J.

“…Restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) remains the preferred surgical option for medically refractory ulcerative colitis…”
Get full text

Gastrointestinal Involvement of Eosinophilic Granulomatosis with Polyangiitis with Histological Evidence of Treatment Response by Lai, Mark, He, Tony, Wright, Emily K.

“…Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic vasculitis of small to medium vessels. Gastrointestinal involvement is uncommon and is…”
Get full text

Luminal microbiota related to Crohn's disease recurrence after surgery by Hamilton, Amy L., Kamm, Michael A., De Cruz, Peter, Wright, Emily K., Feng, Hai, Wagner, Josef, Sung, Joseph J. Y., Kirkwood, Carl D., Inouye, Michael, Teo, Shu-Mei

“…Microbial factors are likely to be involved in the recurrence of Crohn's disease (CD) after bowel resection. We investigated the luminal microbiota before and…”
Get full text

Magnetic resonance enterography for predicting the clinical course of Crohn's disease strictures by Schulberg, Julien D, Wright, Emily K, Holt, Bronte A, Sutherland, Tom R, Hume, Simon J, Hamilton, Amy L, Ross, Alyson L, Connell, William C, Brown, Steven J, Lust, Mark, Miller, Ashley M, Bell, Sally J, Kamm, Michael A

“…Background and Aims Strictures are the most common Crohn's disease complication, but their natural history is unknown. This study aimed to characterize…”
Get full text

Corrigendum: Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α by Spencer, Elizabeth A, Dubinsky, Marla C, Kamm, Michael A, Chaparro, Maria, Gionchetti, Paolo, Rizzello, Fernando, Gisbert, Javier P, Wright, Emily K, Schulberg, Julien D, Hamilton, Amy L, McGovern, Dermot P B, Dervieux, Thierry

“…[This corrects the article DOI: 10.3389/fimmu.2024.1342477.]…”
Get full text

Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α by Spencer, Elizabeth A, Dubinsky, Marla C, Kamm, Michael A, Chaparro, Maria, Gionchetti, Paolo, Rizzello, Fernando, Gisbert, Javier P, Wright, Emily K, Schulberg, Julien D, Hamilton, Amy L, McGovern, Dermot P B, Dervieux, Thierry

“…We evaluated baseline Clearance of anti-tumor necrosis factors and human leukocyte antigen variant (HLA DQA1*05) in combination as poor prognostic factors…”
Get full text

Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial by Little, Robert D, McKenzie, Jo, Srinivasan, Ashish, Hilley, Patrick, Gilmore, Robert B, Chee, Desmond, Sandhu, Manjeet, Saitta, Daniel, Chow, Elizabeth, Thin, Lena, Walker, Gareth J, Moore, Gregory T, Lynch, Kate, Andrews, Jane, An, Yoon K, Bryant, Robert V, Connor, Susan J, Garg, Mayur, Wright, Emily K, Hold, Georgina, Segal, Jonathan P, Boussioutas, Alex, De Cruz, Peter, Ward, Mark G, Sparrow, Miles P

“…IntroductionA substantial proportion of patients with inflammatory bowel disease (IBD) on intravenous infliximab require dose intensification. Accessing…”
Get full text

Transperineal ultrasonography in perianal Crohn disease: A valuable imaging modality by Wright, Emily K, Novak, Kerri L, Lu, Cathy, Panaccione, Remo, Ghosh, Subrata, Wilson, Stephanie R

“…Aims of treatment for Crohn disease have moved beyond the resolution of clinical symptoms to objective end points including endoscopic and radiological…”
Get full text

Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn’s Disease by Wright, Emily K, Kamm, Michael A, De Cruz, Peter, Hamilton, Amy L, Selvaraj, Fabiyola, Princen, Fred, Gorelik, Alexandra, Liew, Danny, Prideaux, Lani, Lawrance, Ian C, Andrews, Jane M, Bampton, Peter A, Jakobovits, Simon L, Florin, Timothy H, Gibson, Peter R, Debinski, Henry, Macrae, Finlay A, Samuel, Douglas, Kronborg, Ian, Radford-Smith, Graham, Gearry, Richard B, Selby, Warwick, Bell, Sally J, Brown, Steven J, Connell, William R

“…Abstract Background Anti-TNF prevents postoperative Crohn’s disease recurrence in most patients but not all. This study aimed to define the relationship…”
Get full text

Cost-effectiveness of Crohn’s disease post-operative care by Wright, Emily K, Kamm, Michael A, Dr Cruz, Peter, Hamilton, Amy L, Ritchie, Kathryn J, Bell, Sally J, Brown, Steven J, Connell, William R, Desmond, Paul V, Liew, Danny

“…AIM: To define the cost-effectiveness of strategies, including endoscopy and immunosuppression, to prevent endoscopic recurrence of Crohn’s disease following…”
Get full text

Management of inflammatory bowel disease by Wright, Emily K, Ding, Nik S, Niewiadomski, Ola

“…Summary Australia has one of the highest incidence rates of inflammatory bowel disease (IBD) in the world. Early diagnosis and treatment for IBD is critical…”
Get full text

Fecal microbiota transplantation therapy in Crohn's disease: Systematic review by Fehily, Sasha R, Basnayake, Chamara, Wright, Emily K, Kamm, Michael A

“…Background The gastrointestinal microbiota is the key antigenic drive in the inflammatory bowel diseases. Randomized controlled trials (RCTs) in ulcerative…”
Get full text

Crohn stricture resolution following treatment with high‐dose ustekinumab by Gupta, Rachit, Wright, Emily K.

Get full text

Letter Response to: Hernandez-Rocha C et al, Clin Gastroenterol Hepatol 2024 by Wright, Emily K., Kamm, Michael A.

Get full text

Recent advances in characterizing the gastrointestinal microbiome in Crohn's disease: a systematic review by Wright, Emily K, Kamm, Michael A, Teo, Shu Mei, Inouye, Michael, Wagner, Josef, Kirkwood, Carl D

“…The intestinal microbiota is involved in the pathogenesis of inflammatory bowel disease. A reduction in the diversity of the intestinal microbiota as well as…”
Get full text

Hydrogel-based and spheroid-based autologous chondrocyte implantation of the knee show similar 2-year functional outcomes: An analysis based on the German Cartilage Registry (KnorpelRegister DGOU) by Bumberger, Alexander, Niemeyer, Philipp, Angele, Peter, Wright, Emily K, Faber, Svea O

“…To compare short-term patient-reported outcomes (PRO) of two contemporary matrix-associated autologous chondrocyte implantation (M-ACI) products for the…”
Get full text

Review of long‐term complications and functional outcomes of ileoanal pouch procedures in patients with inflammatory bowel disease by Hassan, Yusuf, Connell, William R., Rawal, Alisha, Wright, Emily K.

“…Background In medically refractory Ulcerative Colitis (UC), proctocolectomy with ileoanal pouch procedure (IAPP) is the preferred continence‐preserving…”
Get full text

Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical and endoscopic remission in refractory moderate to severe ulcerative colitis by Gupta, Rachit, Schulberg, Julien D., Niewiadomski, Ola, Wright, Emily K.

Get full text

Calprotectin or Lactoferrin: Do They Help by Wright, Emily K

“…The diagnosis and monitoring of inflammatory bowel disease (IBD) has traditionally relied on clinical assessment, serum markers of inflammation and endoscopic…”
Get more information